No data

No data

1993

1995

2001

2007

2008

2009

2011

2012

2013

2014

2015

2016

2017

2018

2019

2025

1993
1995
2001
2007
2008
2009
2011
2012
2013
2014
2015
2016
2017
2018
2019
2025

  • Beijing Kinghawk Pharmaceutical Co., Ltd. was established

  • Kinghawk Pharmaceutical Obtains AIDS Drug Approval Number

  • Kinghawk Pharmaceutical develops biosafety reagents

  • Kinghawk Pharmaceutical Obtains Hepatitis E Approval Number

  • Shanghai Kexin Biotechnology Co., Ltd. was established

  • Kinghawk Pharmaceutical Services Olympic Security

  • Zhongshan REF Medical Science & Technology Co., Ltd. was established

  • Kinghawk Pharmaceutical Obtains Approval Number for Influenza A

  • Kinghawk Pharmaceutical has obtained ISO/IEC 17025 laboratory accreditation

  • Kinghawk Pharmaceutical participates in the "Twelfth Five-Year Plan" Beijing Engineering Laboratory project

  • Kexin Biotech completes investment and acquisition of REF Medical

  • Kinghawk Pharmaceutical develops H7N9 detection reagent

  • Guizhou Ankang Medical Testing Center Established

  • Kinghawk Pharmaceutical's new HIV diagnostic reagent approved for market release by the US CDC and China CDC

  • Kexin Biotech completes investment and acquisition of Kinghawk Pharmaceutical

  • Kinghawk Pharmaceutical passed the 2010 edition of drug GMP

  • Kexin Biotech's products for autoimmune disease diagnosis, including antinuclear antibody panel, autoimmune liver panel, and vasculitis antibody panel, have been approved for market release.

  • Kexin Biotech completes investment and acquisition of Ankang Diagnostics

  • Kinghawk Pharmaceutical participates in the "13th Five-Year" national project

  • Defu Investment invests in Kexin Biotech

  • Ankang Diagnostics obtained the CMA qualification certificate

  • Kinghawk Pharmaceutical develops COVID-19 testing reagents

  • Kexin Biotech's self-developed fully automatic immunoblotting instrument approved for market launch

  • Ankang Diagnostics Obtained ISO15189 Quality System Accreditation Certificate

  • Complete the group's optimization and layout adjustment, advancing towards higher development goals